河南2025年新增专精特新"小巨人"企业54家 来源：中国新闻网 编辑：万可义 广告等商务合作，请点击这里 本文为转载内容，授权事宜请联系原著作权人 中新经纬版权所有，未经书面授权，任何单位及个人不得转载、摘编或以其它方式使用。 关注中新经纬微信公众号(微信搜索"中新经纬"或"jwview")，看更多精彩财经资讯。 中新网郑州1月7日电 (王宇)1月6日至7日，河南省工业和信息化工作会议在郑州召开。会议通报称， 2025年，该省新增专精特新"小巨人"企业54家，22家企业入围中国制造业企业500强。 2025年1至11月，该省规上工业增加值、工业投资分别同比增长8.4%、15.7%，双双位居中国10个工业 大省首位；10个重点行业对全省规上工业增长的贡献率达54.6%，新一代信息技术、新能源汽车、高端 装备、新材料行业增加值分别增长18.6%、17.3%、10%、9.4%，全省规上高技术制造业、工业战略性 新兴产业增加值同比分别增长15.7%和12.5%。 通报称，2025年，该省新培育国家级装备首台套产品7个，新认定省级"五首"产品152件，新认定卓越级 智能工厂16家、省级智能工厂和车间323个，新培育数 ...

本报讯 （记者肖艳青）1月5日晚间，中信重工机械股份有限公司（以下简称"中信重工"）公告称，公 司凭借"冶金回转窑"产品获得"第九批制造业单项冠军企业"认定。 （编辑 黄力） 据悉，中信重工作为国内冶金回转窑行业的领导者，设计制造了国内活性石灰、红土镍矿、冶金球团及 铬铁等多个行业最大规格的冶金回转窑，有力带动上游国产配套产品的更新迭代，打破了大规格冶金回 转窑进口的局面，推动下游冶金装备行业装备升级，促进国内冶金装备行业大型化、智能化、绿色化发 展。 中信重工表示，公司本次获得"第九批制造业单项冠军企业"认定，是对公司产品技术、质量的高度认 可，是公司行业地位、自主创新能力等综合实力的体现。公司将继续聚焦社会行业亟需，持续加强技术 创新，不断提高核心竞争力，稳步提升公司行业份额，推动行业智能化、绿色化、融合化发展。 公告显示，截至目前，中信重工已拥有矿物磨机、矿井提升机、智能防爆机器人、冶金回转窑四项单项 冠军产品。 ...

Core Viewpoint - The Ministry of Industry and Information Technology has officially announced the ninth batch of national-level manufacturing single champion enterprises, with RIFENG Group Co., Ltd. winning the title for its PP-R healthy drinking water pipeline system, highlighting its core competitiveness and contribution to housing quality upgrades and national housing construction [1] Group 1: Recognition and Achievement - RIFENG has been recognized as a "national-level manufacturing single champion enterprise," a prestigious honor in China's manufacturing sector, aimed at companies that excel in specific sub-sectors and achieve international advanced levels in production technology or processes [1] - The title reflects RIFENG's long-term focus on the pipeline industry and its leading market share in the PP-R pipe segment, which is crucial for the innovation and development of the manufacturing industry [1] Group 2: Product Innovation and Safety - RIFENG has dedicated nearly 30 years to the pipeline sector, emphasizing user safety and health, leading to continuous product innovation and systematic upgrades [3] - The PP-R ceramic core antibacterial pipe features a patented technology that addresses traditional pipe issues, ensuring smooth water flow and long-term use without scaling [3] - The antibacterial technology, verified by the Guangdong Microbiology Analysis Testing Center, shows a 99.9% antibacterial rate against Staphylococcus aureus and Escherichia coli, meeting high safety standards [3][6] Group 3: Smart Manufacturing and Sustainability - RIFENG is embracing digitalization and green transformation, integrating advanced technologies like 5G, big data, and AI into its production processes to enhance quality and efficiency [4][5] - The company has established a dynamic monitoring and comprehensive management system for pollution sources, adhering to green building standards in its facilities [5] - RIFENG is committed to clean production, implementing solar power systems and waste heat recovery systems to significantly reduce emissions of CO, SO2, and particulate matter [5] Group 4: Future Focus - Moving forward, RIFENG aims to continue focusing on key technological advancements in health drinking water and building pipeline sectors, enhancing quality management, smart manufacturing, and green low-carbon levels [5]

Group 1 - Lanzhou Lanshi Heavy Equipment Co., Ltd. (referred to as "Lanshi Heavy Equipment") announced that its subsidiaries, Lanzhou Lanshi Heat Exchange Equipment Co., Ltd. (referred to as "Heat Exchange Company") and Qingdao Lanshi Heavy Machinery Equipment Co., Ltd. (referred to as "Qingdao Company"), have obtained important qualification recognitions [2] - The Heat Exchange Company has been recognized as a national-level "specialized, refined, distinctive, and innovative" small giant enterprise, which is part of the seventh batch of such enterprises in Gansu Province [2] - The Heat Exchange Company, established in 1965, is the only state-owned enterprise in the field of plate heat exchangers and has a leading position in technology, equipment level, and production scale in the domestic industry [2] Group 2 - The Heat Exchange Company has developed over 100 series of products, including detachable plate heat exchangers and welded plate heat exchangers, achieving domestic leading and international advanced levels in several areas [3] - Qingdao Company has been recognized as a high-tech enterprise, allowing it to enjoy preferential tax policies for three consecutive years, with a corporate income tax rate of 15% [3] - Qingdao Company has also been included in the list of "Shandong Province Manufacturing Single Champion Enterprises," which recognizes its excellence in manufacturing [3] Group 3 - Qingdao Company focuses on high-end equipment manufacturing for refining and chemical industries, providing core equipment with high technical content and added value [4] - The recognition of the subsidiaries as specialized, high-tech, and manufacturing champions reflects their comprehensive development strength in R&D, technological innovation, and product services [4] - This recognition is expected to enhance Lanshi Heavy Equipment's competitiveness and influence in the energy-saving and traditional energy chemical equipment sectors [4]

Group 1 - The company announced that its subsidiary, Lanzhou Lanshi Heat Exchange Equipment Co., Ltd., has been recognized as a "Little Giant" enterprise in the seventh batch of national specialized and innovative enterprises [1] - Another subsidiary, Qingdao Lanshi Heavy Machinery Equipment Co., Ltd., has been certified as a national high-tech enterprise and selected as a champion enterprise in the manufacturing sector in Shandong Province [1] - These recognitions reflect the subsidiaries' strengths in R&D, technological innovation, specialization, and overall development capabilities, enhancing the company's competitiveness and influence in the energy conservation and traditional energy chemical equipment sectors [1]

Group 1: Manufacturing Champions Recognition - Shandong Province's Industrial and Information Technology Department has announced the ninth batch of proposed manufacturing champions, with two companies from Linyi's Luozhuang District, including Luoxin Pharmaceutical and Lixin Aluminum, successfully recognized [1] - Luozhuang District has now cultivated a total of 1 national-level and 10 provincial-level manufacturing champions, creating a "1+10" champion enterprise matrix to enhance the region's manufacturing capabilities [1] Group 2: Luoxin Pharmaceutical Innovations - Luoxin Pharmaceutical, a top 100 pharmaceutical company in China, specializes in digestive system diseases and has developed the first domestically produced potassium ion competitive acid blocker, Tegoprazan (brand name: Taixinzan), which has received approval for three indications [4] - The drug is notable for its rapid onset of action within 30 minutes, long-lasting acid suppression, and convenience of use, with all three indications included in the national medical insurance catalog by 2025 [4] - Luoxin has been recognized multiple times for its contributions to the pharmaceutical industry, including national and provincial awards, and has established a comprehensive innovation capability across drug research, production, trade, and healthcare services [4] Group 3: Lixin Aluminum's Green Initiatives - Lixin Aluminum is recognized for its "short-process green industrial chain," achieving over 90% secondary utilization of aluminum resources through its recycling and processing model [8] - The company has an annual production capacity of 100,000 tons, which will increase to 300,000 tons per year after the completion of a new green recycled aluminum alloy project in 2024, with expected annual sales revenue of 2.5 billion yuan [8] - Lixin holds 14 national invention patents and 42 utility model patents, and has established multiple research and development platforms in collaboration with universities, achieving some technologies at an internationally advanced level [8] Group 4: Policy Support and Development Strategies - The Luozhuang District's Industrial and Information Technology Bureau aims to strengthen the cultivation mechanism for manufacturing champions through targeted policy guidance and financial support [9] - The district encourages companies to overcome critical technological challenges and promotes the transformation of scientific achievements [9] - The focus is on building a collaborative industrial community that integrates leading enterprises with small and medium-sized suppliers, leveraging the innovations of Luoxin and Lixin to elevate the entire industrial chain [9]

Group 1: Business Integration and Strategy - The company has completed the acquisition of 60% equity in Shenzhen ABB and plans to integrate operations focusing on cost efficiency, technology development, and market channel collaboration [2][3] - Cost efficiency will be achieved by supplying magnetic components directly to the acquired company, reducing procurement and logistics costs [2] - The company aims to leverage Shenzhen ABB's global channel network, covering over 70 countries, to accelerate international market entry and reduce certification time [2][3] Group 2: Product Development and Market Position - The company's chip network transformers have been recognized as a national "manufacturing single champion" product, showcasing its expertise in this niche [4] - The transformers are essential for data transmission and are used in various network communication devices, with a focus on high integration, low loss, and automated production [4] - The company has developed a complete power magnetic solution for AI servers and data centers, enhancing energy efficiency for major global clients [5] Group 3: Competitive Advantages and Market Expansion - The company adopts a global cost-leading strategy for its optical modules and has expanded its business model to include ODM/JDM partnerships, avoiding direct competition with downstream manufacturers [6] - Multiple production bases have been established in Dongguan, Henan, Jiangxi, Wuhan, and Vietnam, enhancing production flexibility and supply chain resilience [8] - Sales branches have been set up in the USA, Singapore, and Malaysia to effectively cover core markets in North America and Southeast Asia [8]

Core Insights - The recent adjustment of core indices in the Shenzhen market, including the Shenzhen Component Index and ChiNext Index, signals a shift towards supporting national strategies and promoting high-quality development in China's capital market [1][2] - The weight of strategic emerging industries in the ChiNext Index has reached 93%, and 98% in the ChiNext 50, with nearly half of the new generation information technology sectors such as artificial intelligence and chips represented [1][2] Group 1 - The adjustment reflects a transition from "traditional industry barometer" to "new productivity indicator," indicating a commitment to deepening the socialist market economy and aligning the capital market with national industrial strategies [1][2] - The core logic of this adjustment is centered around two key concepts: strategic emerging industries and manufacturing champions, which represent the future competitive landscape and the true height of Chinese manufacturing in the global value chain [1][2] Group 2 - The adjustment enhances the capital market's role in serving the real economy, guiding more long-term capital towards high-tech and high-growth sectors, thus creating a virtuous cycle of "technology-industry-finance" [2][3] - The new sample companies in the ChiNext Index have shown a 13% year-on-year increase in R&D expenses, with 30 companies having R&D intensity exceeding 10%, indicating that the index adjustment is based on genuine innovation capabilities and industrial contributions [2][3] Group 3 - The adjustment provides higher quality asset allocation tools for investors, as the new index samples maintain financial stability while increasing the "hard technology" content [3] - The total dividends from the Shenzhen 100 sample companies reached 302.2 billion yuan, accounting for 55% of the total in the Shenzhen market, demonstrating that new productivity and shareholder returns can coexist [3] Group 4 - The adjustment is seen as a critical step towards deeper integration of the capital market with industrial upgrades, emphasizing the need for continued efforts in registration system reform, delisting mechanisms, information disclosure, and investor protection [3] - The capital market is positioned to become an incubator and accelerator for new productivity in the context of China's modernization process, rather than a guardian of outdated models [3]

Core Insights - Jiangsu Province's Ministry of Industry and Information Technology announced the ninth batch of national manufacturing single champion enterprises, with Shanshan Co., Ltd.'s subsidiary, Shanjin Optoelectronics (Nanjing) Co., Ltd., winning the title for its core product, "polarizers" [2] - Shanshan has now accumulated three national manufacturing single champion honors across key sectors: lithium battery anode materials, cathode materials, and optical display core materials (polarizers), establishing a "triple crown" industry landscape [2] - The national manufacturing single champion title is a prestigious recognition in the manufacturing sector, evaluating companies based on market focus, technological leadership, global market share, and brand influence [2] Polarizer Sector - Shanjin Optoelectronics is a leading domestic player in the polarizer industry, adhering to a "quality innovation" philosophy and driving development through technological breakthroughs [2] - The company has overcome multiple process barriers, achieving international advanced levels in optical performance, stability, and weather resistance for its self-developed polarizers, which are widely used in LCD TVs, laptops, smartphones, and automotive displays [2] - This development significantly alleviates the long-standing reliance on imports for high-end polarizers in China [2] Anode Materials Sector - Shanshan Technology is the first company in China to industrialize lithium battery anode materials, continuously leading technological innovation [3] - The company maintains a leading market share in artificial graphite products, with breakthroughs in ultra-fast charging graphite and high energy density 6C ultra-fast charging anodes, supplying major global battery manufacturers [3] - In the energy storage sector, Shanshan's long-cycle graphite supports over 15,000 charge cycles, and it has made significant advancements in silicon-carbon composite technologies for solid-state batteries [3] Cathode Materials Sector - Shanshan has been involved in the research and production of battery cathode materials since 2003 [3] - The joint venture with BASF, established in 2021, has achieved an annual production capacity of approximately 100,000 tons for cathode active materials, covering a wide range of products for electric vehicles and consumer electronics [3] - Shanshan is recognized as one of the leading suppliers of battery cathode materials in the industry [3] Future Outlook - Shanshan is committed to continuing innovation and strengthening its core competitiveness, aiming to achieve breakthroughs and leadership in more key material sectors [3] - The company plays a vital role in promoting import substitution and technological advancement in related industries, contributing to the high-quality development of China's manufacturing sector [3]

Core Insights - 甘李药业 has been recognized as a manufacturing single champion enterprise, marking its status as a leading company in the biopharmaceutical sector with its core product, "Insulin Glargine Injection" [1][2] - The recognition reflects 甘李药业's advanced production technology and significant market share in the insulin analogs field, breaking the long-standing foreign monopoly in the domestic insulin market [1][2] Group 1: Company Achievements - 甘李药业 has established a self-controlled production system and a complete product line, including long-acting, rapid-acting, and premixed insulin [2] - The company has successfully passed the European Medicines Agency (EMA) GMP inspection, laying a solid foundation for entering the global regulated market [2] - In the first three quarters of 2025, domestic formulation revenue reached 2.624 billion yuan, a year-on-year increase of 45.6%, indicating a robust recovery in the domestic market [2] Group 2: Innovation and Future Prospects - Under the leadership of CEO Dr. Chen Wei, 甘李药业 is accelerating the development and global registration of innovative drugs, transitioning from "China's first imitation" to "global first creation" [3] - The company is expected to play a more significant role in the global value chain of the pharmaceutical industry, driven by steady growth in the domestic procurement market and accelerated expansion in the international high-end market [3]